全文获取类型
收费全文 | 7839篇 |
免费 | 859篇 |
国内免费 | 2篇 |
出版年
2023年 | 46篇 |
2022年 | 67篇 |
2021年 | 187篇 |
2020年 | 110篇 |
2019年 | 134篇 |
2018年 | 163篇 |
2017年 | 157篇 |
2016年 | 230篇 |
2015年 | 367篇 |
2014年 | 408篇 |
2013年 | 456篇 |
2012年 | 619篇 |
2011年 | 616篇 |
2010年 | 383篇 |
2009年 | 316篇 |
2008年 | 466篇 |
2007年 | 452篇 |
2006年 | 387篇 |
2005年 | 370篇 |
2004年 | 398篇 |
2003年 | 340篇 |
2002年 | 309篇 |
2001年 | 116篇 |
2000年 | 83篇 |
1999年 | 103篇 |
1998年 | 80篇 |
1997年 | 66篇 |
1996年 | 49篇 |
1995年 | 48篇 |
1994年 | 40篇 |
1993年 | 31篇 |
1992年 | 70篇 |
1991年 | 70篇 |
1990年 | 47篇 |
1989年 | 55篇 |
1988年 | 37篇 |
1987年 | 41篇 |
1986年 | 43篇 |
1985年 | 51篇 |
1984年 | 55篇 |
1983年 | 40篇 |
1982年 | 27篇 |
1981年 | 28篇 |
1980年 | 30篇 |
1979年 | 32篇 |
1978年 | 32篇 |
1977年 | 35篇 |
1976年 | 28篇 |
1974年 | 29篇 |
1972年 | 29篇 |
排序方式: 共有8700条查询结果,搜索用时 203 毫秒
221.
Sarah K. Oettl Jana Gerstmeier Shafaat Y. Khan Katja Wiechmann Julia Bauer Atanas G. Atanasov Clemens Malainer Ezzat M. Awad Pavel Uhrin Elke H. Heiss Birgit Waltenberger Daniel Remias Johannes M. Breuss Joel Boustie Verena M. Dirsch Hermann Stuppner Oliver Werz Judith M. Rollinger 《PloS one》2013,8(10)
In vitro screening of 17 Alpine lichen species for their inhibitory activity against 5-lipoxygenase, microsomal prostaglandin E2 synthase-1 and nuclear factor kappa B revealed Cetrelia monachorum (Zahlbr.) W.L. Culb. & C.F. Culb. As conceivable source for novel anti-inflammatory compounds. Phytochemical investigation of the ethanolic crude extract resulted in the isolation and identification of 11 constituents, belonging to depsides and derivatives of orsellinic acid, olivetolic acid and olivetol. The two depsides imbricaric acid (4) and perlatolic acid (5) approved dual inhibitory activities on microsomal prostaglandin E2 synthase-1 (IC50 = 1.9 and 0.4 µM, resp.) and on 5-lipoxygenase tested in a cell-based assay (IC50 = 5.3 and 1.8 µM, resp.) and on purified enzyme (IC50 = 3.5 and 0.4 µM, resp.). Additionally, these two main constituents quantified in the extract with 15.22% (4) and 9.10% (5) showed significant inhibition of tumor necrosis factor alpha-induced nuclear factor kappa B activation in luciferase reporter cells with IC50 values of 2.0 and 7.0 µM, respectively. In a murine in vivo model of inflammation, 5 impaired the inflammatory, thioglycollate-induced recruitment of leukocytes to the peritoneum. The potent inhibitory effects on the three identified targets attest 4 and 5 a pronounced multi-target anti-inflammatory profile which warrants further investigation on their pharmacokinetics and in vivo efficacy. 相似文献
222.
Tien Chye Tan Oliver Spadiut Thanyaporn Wongnate Jeerus Sucharitakul Iris Krondorfer Christoph Sygmund Dietmar Haltrich Pimchai Chaiyen Clemens K. Peterbauer Christina Divne 《PloS one》2013,8(1)
Pyranose dehydrogenases (PDHs) are extracellular flavin-dependent oxidoreductases secreted by litter-decomposing fungi with a role in natural recycling of plant matter. All major monosaccharides in lignocellulose are oxidized by PDH at comparable yields and efficiencies. Oxidation takes place as single-oxidation or sequential double-oxidation reactions of the carbohydrates, resulting in sugar derivatives oxidized primarily at C2, C3 or C2/3 with the concomitant reduction of the flavin. A suitable electron acceptor then reoxidizes the reduced flavin. Whereas oxygen is a poor electron acceptor for PDH, several alternative acceptors, e.g., quinone compounds, naturally present during lignocellulose degradation, can be used. We have determined the 1.6-Å crystal structure of PDH from Agaricus meleagris. Interestingly, the flavin ring in PDH is modified by a covalent mono- or di-atomic species at the C(4a) position. Under normal conditions, PDH is not oxidized by oxygen; however, the related enzyme pyranose 2-oxidase (P2O) activates oxygen by a mechanism that proceeds via a covalent flavin C(4a)-hydroperoxide intermediate. Although the flavin C(4a) adduct is common in monooxygenases, it is unusual for flavoprotein oxidases, and it has been proposed that formation of the intermediate would be unfavorable in these oxidases. Thus, the flavin adduct in PDH not only shows that the adduct can be favorably accommodated in the active site, but also provides important details regarding the structural, spatial and physicochemical requirements for formation of this flavin intermediate in related oxidases. Extensive in silico modeling of carbohydrates in the PDH active site allowed us to rationalize the previously reported patterns of substrate specificity and regioselectivity. To evaluate the regioselectivity of D-glucose oxidation, reduction experiments were performed using fluorinated glucose. PDH was rapidly reduced by 3-fluorinated glucose, which has the C2 position accessible for oxidation, whereas 2-fluorinated glucose performed poorly (C3 accessible), indicating that the glucose C2 position is the primary site of attack. 相似文献
223.
Aaron R. Everitt Simon Clare Jacqueline U. McDonald Leanne Kane Katherine Harcourt Malika Ahras Amar Lall Christine Hale Angela Rodgers Douglas B. Young Ashraful Haque Oliver Billker John S. Tregoning Gordon Dougan Paul Kellam 《PloS one》2013,8(11)
The interferon-inducible transmembrane (IFITM) family of proteins has been shown to restrict a broad range of viruses in vitro and in vivo by halting progress through the late endosomal pathway. Further, single nucleotide polymorphisms (SNPs) in its sequence have been linked with risk of developing severe influenza virus infections in humans. The number of viruses restricted by this host protein has continued to grow since it was first demonstrated as playing an antiviral role; all of which enter cells via the endosomal pathway. We therefore sought to test the limits of antimicrobial restriction by Ifitm3 using a knockout mouse model. We showed that Ifitm3 does not impact on the restriction or pathogenesis of bacterial (Salmonella typhimurium, Citrobacter rodentium, Mycobacterium tuberculosis) or protozoan (Plasmodium berghei) pathogens, despite in vitro evidence. However, Ifitm3 is capable of restricting respiratory syncytial virus (RSV) in vivo either through directly restricting RSV cell infection, or by exerting a previously uncharacterised function controlling disease pathogenesis. This represents the first demonstration of a virus that enters directly through the plasma membrane, without the need for the endosomal pathway, being restricted by the IFITM family; therefore further defining the role of these antiviral proteins. 相似文献
224.
225.
Eliane V. Wolf Annett Zei?ler Oliver Vosyka Evelyn Zeiler Stephan Sieber Steven H. L. Verhelst 《PloS one》2013,8(8)
Rhomboids are intramembrane serine proteases that play diverse biological roles, including some that are of potential therapeutical relevance. Up to date, rhomboid inhibitor assays are based on protein substrate cleavage. Although rhomboids have an overlapping substrate specificity, substrates cannot be used universally. To overcome the need for substrates, we developed a screening assay using fluorescence polarization activity-based protein profiling (FluoPol ABPP) that is compatible with membrane proteases. With FluoPol ABPP, we identified new inhibitors for the E. coli rhomboid GlpG. Among these was a structural class that has not yet been reported as rhomboid inhibitors: β-lactones. They form covalent and irreversible complexes with the active site serine of GlpG. The presence of alkyne handles on the β-lactones also allowed activity-based labeling. Overall, these molecules represent a new scaffold for future inhibitor and activity-based probe development, whereas the assay will allow inhibitor screening of ill-characterized membrane proteases. 相似文献
226.
227.
Erqi Liu Matthew H. Stenmark Matthew J. Schipper James M. Balter Marc L. Kessler Elaine M. Caoili Oliver E. Lee Edgar Ben-Josef Theodore S. Lawrence Mary Feng 《Translational oncology》2013,6(4):442-446
OBJECTIVES: The full potential of stereotactic body radiation therapy (SBRT), in the treatment of unresectable intrahepatic malignancies, has yet to be realized as our experience is still limited. Thus, we evaluated SBRT outcomes for primary and metastatic liver tumors, with the goal of identifying factors that may aid in optimization of therapy. METHODS: From2005 to 2010, 62 patients with 106 primary and metastatic liver tumors were treated with SBRT to a median biologic effective dose (BED) of 100 Gy (42.6-180). The majority of patients received either three (47%) or five fractions (48%). Median gross tumor volume (GTV) was 8.8 cm3 (0.2-222.4). RESULTS: With a median followup of 18 months (0.46-46.8), freedom from local progression (FFLP) was observed in 97 of 106 treated tumors, with 1- and 2-year FFLP rates of 93% and 82%. Median overall survival (OS) for all patients was 25.2 months, with 1- and 2-year OS of 81%and 52%. Neither BED nor GTV significantly predicted for FFLP. Local failure was associated with a higher risk of death [hazard ratio (HR) = 5.1, P = .0007]. One Child-Pugh Class B patient developed radiationinduced liver disease. There were no other significant toxicities. CONCLUSIONS: SBRT provides excellent local control for both primary and metastatic liver lesions with minimal toxicity. Future studies should focus on appropriate selection of patients and on careful assessment of liver function to maximize both the safety and efficacy of treatment. 相似文献
228.
Oliver Spadiut Simon Rittmann Christian Dietzsch Christoph Herwig 《Engineering in Life Science》2013,13(1):88-101
In this review, we summarise recent studies that purposefully employed dynamic conditions, such as shifts, pulses, ramps and oscillations, for fast physiological strain characterisation and bioprocess development. We show the broad applicability of dynamic conditions and the various objectives that can thereby be investigated in a short time. Dynamic processes reveal information about the analysed system faster than traditional strategies, like continuous cultivations, as process parameters can directly be linked to platform and product parameters. Furthermore, we demonstrate that dynamic operations can result in increased productivity and high product quality, making this strategy a valuable tool for bioprocess development. With this review, we would like to encourage bioprocess engineers to an increased use of dynamic conditions in bioprocess development. 相似文献
229.
230.